Innovent Biologics Inc (6IB) — Free Cash Flow Generation Index
Innovent Biologics Inc (6IB) has a Free Cash Flow Generation Index of 1.97x as of December 2020. Free cash flow of €429.10 Million represents 2% of operating cash flow (€217.96 Million). See working capital position of Innovent Biologics Inc to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Innovent Biologics Inc Free Cash Flow Generation Index (2023–2025)
Historical FCF Generation Index trend for Innovent Biologics Inc across 3 annual periods. Explore 6IB operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Innovent Biologics Inc (2023–2025)
Year-by-year Free Cash Flow Generation Index for Innovent Biologics Inc. For the full company profile including market capitalisation, see 6IB market cap.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | €9.32 Billion | €10.00 Billion | €683.27 Million | ▲ +386.6% |
| 2024 | -0.33x | €-418.39 Million | €1.29 Billion | €1.71 Billion | ▲ +96.1% |
| 2023 | -8.36x | €-1.24 Billion | €147.81 Million | €1.38 Billion | — |